Clearmind Medicine Inc宣布,其研究药物Cmnd-100在最高剂量测试中表现出优异的安全特性,所有受试者均未出现严重不良反应。这一突破性进展为后续临床研究奠定了坚实基础,显示出该药物在安全性方面的显著优势。
Clearmind Medicine Inc宣布,其研究药物Cmnd-100在最高剂量测试中表现出优异的安全特性,所有受试者均未出现严重不良反应。这一突破性进展为后续临床研究奠定了坚实基础,显示出该药物在安全性方面的显著优势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.